IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis.
J Invest Dermatol
; 143(9): 1689-1699, 2023 09.
Article
in En
| MEDLINE
| ID: mdl-36967086
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Psoriasis
/
Dermatologic Agents
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Invest Dermatol
Year:
2023
Document type:
Article
Affiliation country:
United States